The second largest influenza vaccine company in the world to create almost 100 jobs at its Liverpool manufacturing site.
Influenza vaccine manufacturer Seqirus has taken the decision to invest in a new and expanded fill-and-finish facility on the Liverpool site. – image courtesy of Pixabay Influenza vaccine manufacturer Seqirus has taken the decision to invest in a new and expanded fill-and-finish facility on the Liverpool site. The investment will help…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
